Redefining Access Through Biosimilars

Regenix Drugs Ltd [RDL], a non listed public limited company registered with Registrar of Companies in 2007, has its corporate office at Chennai, Tamilnadu, India and is promoted by health care Professionals. We manufacture and market formulations of small molecule and biosimilar products in India. We also export products to CIS, African and Asian countries.

Launch of SustaGlar, a biosimilar long-acting Insulin Glargine (100 IU/mL) for 24HR glycemic control with reduced risk of hypoglycemia

Disposable Pen​

With Sustaglar’s 3 ml low-cost disposable pen, advanced insulin therapy becomes simpler, safer, and more affordable for every individual

Vials

With Sustaglar 3 ml low-cost vials, advanced diabetes care becomes more affordable, reliable, and within everyone’s reach

Reusable Pen

With the Sustaglar Reusable Pen, experience comfort that lasts, a perfect balance of control, care, and confidence in your daily routine

Cartridge

With Sustaglar Cartridges, experience comfort and confidence in every injection, steady support for steady care